11
Views
4
CrossRef citations to date
0
Altmetric
Original

High prevalence of oral colonization by Candida dubliniensis in HIV-positive patients in Argentina

, , , &
Pages 431-437 | Received 22 May 2004, Published online: 09 Jul 2009

References

  • Aguirre Urizar JM. Candidiasis orales. Rev Iberoam Micol 2002; 19: 17–21
  • Sullivan DJ, Westerneng TJ, Haynes KA, et al. Candida dubliniensis sp nov: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV infected individuals. Microbiol 1995; 141: 1507–1521
  • Tintelnot K, Haase G, Seibold M, et al. Evaluation of phenotypic markers for selection and identification of Candida dubliniensis. J Clin Microbiol 2000; 38: 1599–1608
  • Kirkpatrick WR, Revankar SG, McAtee RK, et al. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates. J Clin Microbiol 1998; 36: 3007–3012
  • Tamura M, Watanabe K, Mikani Y, et al. Molecular characterization of new clinical isolates of Candida albicans and Candida dubliniensis in Japan: Analysis reveal a new genotype of Candida albicans with group I intron. J Clin Microbiol 2001; 39: 4309–4315
  • Diaz-Guerra TM, Mellado E, Cuenca Estrella M, et al. Molecular characterization by PCR-fingerprinting of Candida dubliniensis strains isolated from two HIV-positive patients in Spain. Diag Microbiol Infect Dis 1999; 35: 113–119
  • Kamei K, McCullough MJ, Stevens DA. Initial case of Candida dubliniensis infection from Asia: non-mucosal infection. Med Mycol 2000; 38: 81–83
  • Meis M, Jacques FG, Verduyn Lunel FM, et al. One-year prevalence of Candida dubliniensis in a Dutch university hospital. J Clin Microbiol 2000; 38: 3139–3140
  • Blignaut E, Pujol C, Joly S, Soll DR. Racial distribution of Candida dubliniensis colonization among South Africans. J Clin Microbiol 2003; 41: 1838–1842
  • Fotedar R, Aal Hedaithy SSA. Candida dubliniensis at a university hospital in Saudi Arabia. J Clin Microbiol 2003; 41: 1907–1911
  • Sullivan D, Haynes K, Bille J, et al. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals. J Clin Microbiol 1997; 35: 960–964
  • Polacheck I, Strahilevitz J, Sullivan D, et al. Recovery of Candida dublinensis from non-human immunodeficiency virus-infected patients in Israel. J Clin Microbiol 2000; 38: 170–174
  • Silva V, Cabrera M, Díaz MC, et al. Prevalencia de serotipos de Candida albicans en aislamientos de hemocultivo en Chile y primer caso de candidemia por Candida dubliniensis. Rev Iberoam Micol 2003; 20: 46–51
  • Donnelly S, Sullivan DJ, Shanley D, Coleman DC. Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. Microbiol 1999; 145: 1871–1882
  • Jabra-Rizk MA, Falkler WA, Merz WG, et al. Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals. J Clin Microbiol 2000; 38: 2423–2426
  • Moran GP, Sullivan DJ, Henman MC, et al. Antifungal drugs susceptibilities of oral Candida dubliniensis isolated from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob Agents Chemother 1997; 41: 617–623
  • Quindós G, Carrillo-Muñoz AJ, Arévalo MP, et al. In vitro susceptibility of Candida dubliniensis to current and new antifungal agents. Chemotherapy 2000; 46: 395–401
  • Ruhnke M, Schmidt-Westhausen A, Morschhauser J. Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS. J Antimicrob Chemother 2000; 46: 291–295
  • Moran G, Sanglard D, Donnelly S, et al. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob Agents Chemother 1998; 42: 1819–1830
  • Gales AC, Pfaller AK, Houston S, et al. Identification of Candida dubliniensis based on temperature and utilization of xylose and α-methyl-D-glucoside as determined with the API 20C Aux and Vitek YBC Systems. J Clin Microbiol 1999; 37: 3804–3808
  • Al Mosaid A, Sullivan D, Salkin IF, et al. Differentiation of Candida dubliniensis from Candida albicans on Staib agar and caffeic acid-ferric citrate agar. J Clín Microbiol 2001; 39: 323–327
  • Slifkin M. Tween 80 opacity test responses of various Candida species. J Clin Microbiol 2000; 38: 4626–4628
  • Mosca CO, Moragues MD, Llovo J, et al. Casein agar: a useful medium for differentiating Candida dubliniensis from Candida albicans. J Clin Microbiol 2003; 41: 1259–1262
  • Thanos M, Schonian G, Meyer W, et al. Rapid identification of Candida species by DNA fingerprinting with PCR. J Clin Microbiol 1996; 34: 615–621
  • Joly S, Pujol C, Rysz M, et al. Development and characterization of complex DNA fingerprinting probes for the infectious yeast Candida dubliniensis. J Clin Microbiol 1999; 37: 1035–1044
  • Rodero L, Losso M, Canteros C, et al. Candida dubliniensis: primer aislamiento en Argentina. Rev Arg Microbiol 1998; 30: 39–41
  • Al Mosaid A, Sullivan DJ, Coleman DC. Differentiation of Candida dubliniensis from Candida albicans on Pal's Agar. J Clin Microbiol 2003; 41: 4787–4789
  • Mitchell TG, Freedman EZ, Meyer W, . PCR identification of Cryptococcus neoformans. Diagnostic Molecular Microbiology. Principles and Applications, DH Persing, TF Smith, C Tenover, TJ White, et al. American Society for Microbiology, Washington, DC 1994; 431–436
  • Pipolo Milán E, de Laet Sant'Ana P, Salles de Azevedo Melo A, et al. Multicenter prospective surveillance of oral Candida dubliniensis among adult Brazilian human immunodeficiency virus-positive and AIDS patients. Diag Microbiol Infec Dis 2001; 41: 29–35
  • Sullivan DJ, Moran G, Donnelly S, et al. Candida dubliniensis: an update. Rev Iberoam Micol 1999; 16: 72–76
  • Meiller TF, Jabra-Rizk MA, Baqui A, et al. Oral Candida dubliniensis as clinically important species in HIV-seropositive patients in United States. Oral Surg Oral Med Oral Path Oral Radiol Endodontics 1999; 88: 573–580
  • Giammanco GM, Pizzo G, Pecorella S, et al. Identification of Candida dubliniensis among oral yeast isolates from an Italian population of human immunodeficiency virus-infected (HIV + ) subjects. Oral Microbiol Immunol 2002; 17: 89–94
  • Jabra-Rizk MA, Brenner TM, Romagnoli M, et al. Evaluation of a reformulated CHROMagar Candida. J Clin Microbiol 2001; 39: 2015–2016
  • Jabra-Rizk MA, Baqui AA, Kelley JI, et al. Identification of Candida dubliniensis in a prospective study of patients in the Unites States. J Clin Microbiol 1999; 37: 321–326
  • Kurzai O, Korting HC, Harmsen D, et al. Molecular and phenotypic identification of the yeast pathogen Candida dubliniensis. J Molec Med 2000; 78: 521–529
  • Pincus DH, Coleman DC, Pruitt WR, et al. Rapid identification of Candida dubliniensis with commercial yeast identification systems. J Clin Microbiol 1999; 37: 3533–3539

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.